Sun Pharmaceuticals Ltd reported Total revenue for Q4 FY23 of ₹10,931 Crore, up from ₹9,447 Crore year on year depicting a growth of 16%. Consolidated Net Profit of ₹1,984 Crore, up 187% from -(₹2,227) Crore in the same quarter of the previous year. The Earnings per Share is ₹8.3, up 187% from -(₹9.49) in the same quarter of the previous year.
Sun Pharmaceuticals Ltd Q4FY23 results out, revenue grows by 16%
Related Post
- Syngene Q3 FY26 Earnings Results
Syngene (established in 1993) as a Biocon subsidiary is India's first Contract Research Organization (CRO)…
-
Grindwell Norton Q2 FY26 Earnings Results
Grindwell Norton Limited, engaged in manufacturing abrasives, ceramics & plastics and providing IT services, reported…
-
H.G. Infra Q2 FY26 Earnings Results
H.G. Infra Engineering Limited (HGIEL), an Indian road infrastructure company engaged in EPC services, maintenance…